Nicorandil, a unique dual pharmacological mechanism anti-anginal agent with adenosine
triphosphate sensitive potassium (K ATP) channel agonist and nitrate-like properties …

Nicorandil is a well-known antianginal agent, which has been recommended as one of the
second-line treatments for chronic stable angina as justified by the European guidelines. It …

BACKGROUND: Previous studies showed that nicorandil can reduce coronary events in
patients with coronary artery disease. However, it is unclear whether oral nicorandil …

Objective There is controversy whether nicorandil treatment has cardioprotective effects in
patients with acute myocardial infarction (AMI) following percutaneous coronary intervention …

Background: It is controversial as to whether nicorandil would have cardioprotective effects
in patients with acute myocardial infarction (AMI) who are undergoing reperfusion therapy. A …

Early reperfusion of totally occluded coronary arteries with thrombolysis and/or
percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) reduces …

Background Nicorandil, an adenosine triphosphate-sensitive potassium channel agonist
and nitric oxide donor, is a coronary vasodilator used to treat ischemia-induced chest pain …

Background Using the current meta-analysis as well as systematic review, to determine the
curative effect of Nicorandil in comparison of no Nicorandil after elective percutaneous …

Diabetes is commonly associated with increased risk of cardiovascular morbidity and
mortality. Perturbations in sympathetic nervous system (SNS) signaling have been linked to …

Objective: Currently, there is still no effective strategy to diminish the infarct size (IS) in
patients with ST-segment elevation myocardial infarction (STEMI). According to a previous …